We are live on ! Find out more
FI

FCM Investments Portfolio holdings

AUM $70.1M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+26.28%
3 Year Est. Return
+40.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$131M
AUM Growth
-$27.7M
Cap. Flow
-$33.2M
Cap. Flow %
-25.35%
Top 10 Hldgs %
69.97%
Holding
86
New
–
Increased
–
Reduced
26
Closed
38
Avg Time Held
14.3 quarters
Top 10 Avg Time Held
9 quarters
Top 20 Avg Time Held
10.3 quarters

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.63M
2
ISRG icon
Intuitive Surgical
ISRG
+$3.08M
3
CSCO icon
Cisco
CSCO
+$2.98M
4
VRSK icon
Verisk Analytics
VRSK
+$2.47M
5
CELG
Celgene Corp
CELG
+$2.32M

Sector Composition

Rank Sector Weight
1 Technology 23.22%
2 Miscellaneous 23.05%
3 Communication Services 21.94%
4 Healthcare 20.28%
5 Industrials 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RYN icon
26
Rayonier
RYN
$5.53B
$797K 0.61%
30,521
-7,054
-19% -$182K
2013 Q2
16 quarters
VZ icon
27
Verizon
VZ
$193B
$741K 0.57%
16,603
-4,250
-20% -$198K
2013 Q2
16 quarters
APU
28
DELISTED
AmeriGas Partners, L.P.
APU
$737K 0.56%
16,314
-3,450
-17% -$155K
2013 Q2
16 quarters
T icon
29
AT&T
T
$170B
$711K 0.54%
24,967
-5,428
-18% -$160K
2013 Q2
16 quarters
PFE icon
30
Pfizer
PFE
$159B
$700K 0.53%
21,955
-4,954
-18% -$156K
2013 Q2
16 quarters
EPD icon
31
Enterprise Products Partners
EPD
$79.4B
$689K 0.53%
25,450
-5,700
-18% -$154K
2013 Q2
16 quarters
MMP
32
DELISTED
Magellan Midstream Partners, L.P.
MMP
$609K 0.47%
8,540
-2,100
-20% -$154K
2013 Q2
16 quarters
STX icon
33
Seagate
STX
$176B
$599K 0.46%
15,460
-3,600
-19% -$157K
2015 Q3
7 quarters
RDS.B
34
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$591K 0.45%
10,855
-2,450
-18% -$136K
2013 Q2
16 quarters
MSFT icon
35
Microsoft
MSFT
$3.88T
$538K 0.41%
7,800
– –
2013 Q2
16 quarters
MXIM
36
DELISTED
Maxim Integrated Products
MXIM
$478K 0.37%
10,650
-21,104
-66% -$969K
2013 Q2
16 quarters
GSK icon
37
GSK
GSK
$93.2B
$446K 0.34%
8,280
-15,374
-65% -$820K
2013 Q2
16 quarters
KMB icon
38
Kimberly-Clark
KMB
$32.5B
$352K 0.27%
2,730
-4,650
-63% -$605K
2013 Q2
16 quarters
META icon
39
Meta Platforms (Facebook)
META
$1.84T
$325K 0.25%
2,150
– –
2016 Q2
4 quarters
JNJ icon
40
Johnson & Johnson
JNJ
$618B
$324K 0.25%
2,450
– –
2013 Q2
16 quarters
BKNG icon
41
Booking.com
BKNG
$120B
$309K 0.24%
4,125
– –
2013 Q2
16 quarters
UNP icon
42
Union Pacific
UNP
$165B
$301K 0.23%
2,766
– –
2013 Q2
16 quarters
CMI icon
43
Cummins
CMI
$71.6B
$260K 0.2%
1,600
– –
2013 Q2
16 quarters
PAA icon
44
Plains All American Pipeline
PAA
$17.2B
$248K 0.19%
9,450
-25,884
-73% -$717K
2013 Q2
16 quarters
RTN
45
DELISTED
Raytheon Company
RTN
$242K 0.18%
1,500
– –
2016 Q3
3 quarters
MA icon
46
Mastercard
MA
$503B
$231K 0.18%
1,900
– –
2013 Q2
16 quarters
MMM icon
47
3M
MMM
$84.4B
$229K 0.18%
1,316
– –
2013 Q2
16 quarters
UNH icon
48
UnitedHealth
UNH
$333B
$204K 0.16%
1,100
– –
2013 Q2
16 quarters
ABBV icon
49
AbbVie
ABBV
$481B
– –
-7,500
Closed -$489K –
ABT icon
50
Abbott
ABT
$170B
– –
-6,600
Closed -$293K –
1
2
3 4

Similar funds

YCM
Yorkville Capital Management New York $82.8M AUM 0.41% 1-Year Est. Return
MIM
MPI Investment Management Hinsdale, Illinois $83.5M AUM
HC
Hawkins Capital Houston, Texas $55.4M AUM 11.38% 1-Year Est. Return
KCM
KSA Capital Management Morristown, New Jersey $51.4M AUM 9.96% 1-Year Est. Return
PSW
Portfolio Strategies (Washington) Tacoma, Washington $50.1M AUM 11.94% 1-Year Est. Return
IT
Independence Trust Franklin, Tennessee $90.5M AUM 24.37% 1-Year Est. Return
AZA
Arthur Zaske & Associates Bingham Farms, Michigan $91.5M AUM 9.44% 1-Year Est. Return
SIA
Spruce Investment Advisors Stamford, Connecticut $48.5M AUM 19.92% 1-Year Est. Return

FCM Investments's Q2 2017 Portfolio in Review

As of Q2 2017, FCM Investments held 86 positions worth $131M, down 17% from $159M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

FCM Investments withdrew a net $33.2M in Q2 2017, closing 38 positions and reducing 26 holdings. Its most notable exit was Gilead Sciences, an estimated $3.63M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Miscellaneous and Communication Services.

  • FCM Investments's biggest Q2 2017 reduction was Intuitive Surgical, cutting an estimated $3.08M.
  • FCM Investments fully exited Gilead Sciences in Q2 2017, selling an estimated $3.63M.
  • FCM Investments's ten largest holdings make up 70% of its $131M portfolio in Q2 2017.
  • FCM Investments opened 0 new positions and closed 38 in Q2 2017.
  • FCM Investments's portfolio value fell 17% quarter-over-quarter to $131M.

Based on FCM Investments's 13F filing for Q2 2017, filed 28 Jul 2017.